yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q59136966-7B4B8F53-C7C3-4DEE-9AC7-43A7BE4356BD
Q59136966-7B4B8F53-C7C3-4DEE-9AC7-43A7BE4356BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59136966-7B4B8F53-C7C3-4DEE-9AC7-43A7BE4356BD
Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
P2860
Q59136966-7B4B8F53-C7C3-4DEE-9AC7-43A7BE4356BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59136966-7B4B8F53-C7C3-4DEE-9AC7-43A7BE4356BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78290110a12536f861bc77c13a1a9a306e6c40c0
P2860
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.